Cerebrolysin vs NAP (Davunetide) — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Cerebrolysin is a heterogeneous neuropeptide complex derived from enzymatic hydrolysis of purified porcine brain cortex proteins. Approximately 25% of the preparation consists of low molecular weight peptides (under 10 kDa) that cross the blood-brain barrier, with the remainder b...
Calculate Cerebrolysin dose →NAP (NAPVSIPQ) is an eight-amino-acid neuroprotective peptide derived from Activity-Dependent Neuroprotective Protein (ADNP) - a zinc-finger protein essential for brain formation that is one of the most abundant transcription factors in the brain. First identified by Illana Gozes...
Calculate NAP (Davunetide) dose →| Parameter | Cerebrolysin | NAP (Davunetide) |
|---|---|---|
| Category | Neuropeptides & Cognition | Neuropeptides & Cognition |
| Research | Extensively Studied (Europe/Asia; Not FDA Approved) | Phase II Completed (PSP, Schizophrenia) |
| Half-Life | Short (hours for individual peptides) | 1-3 h (estimated) |
| Typical Dose | 5-30 mL/day IV (pharmaceutical); research 5-10 mL | 30-300 mcg intranasal |
| Frequency | Daily for 10-21 day courses | Twice daily |
| Route | Intravenous, Intramuscular | Intranasal (preferred for CNS delivery) |
| FDA Status | Not Approved (US) | Not Approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.